Overview

From our site in Charles City, IA, USA, we develop and manufacture small molecule APIs, fine chemicals and intermediates for a wide range of applications.

Home to a team of more than 375 employees, the site is comprised of four large scale commercial cGMP production plants, as well as a cGMP pilot plant and cGMP kilo laboratory – each with multiple work centers that allow for simultaneous cGMP production at varied scale.

At our Charles City facility, we currently produce more than 40 APIs per year across our multi-purpose production units.

Our site is also equipped to handle controlled substances, with potent compound development, manufacturing, drying and packaging capabilities.

This Cambrex facility is one of a limited number to be authorized by the Drug Enforcement Administration (DEA) to import narcotic raw materials on a commercial scale.

Explore our other locations

Want to know more about the services available at our other Cambrex locations? Discover our global sites by visiting our main facilities page.

Our Facilities

Facility details

Our Charles City site is fully equipped with state of the art facilities, including the following:

  • 4 cGMP commercial scale production plants
  • 1 cGMP pilot plant
  • 1 cGMP kilo laboratory
  • 350,000L commercial capacity
  • R&D development and analytical laboratories
  • High potency development and manufacturing center
  • Strong regulatory history